The information below is taken from the patent on the Silver Shield products.  See the list of pathogens that this silver destroys without harming essential bacteria for good health or becoming toxic to the human body.

United States Patent	7,135,195
Holladay ,   et al.	November 14, 2006

15. Data Summary



The following table contains a summary of the above results in terms of the effects of the inventive silver composition on a wide variety of microbes and human diseases. In some cases, the data presented in the table is not repeated above. However, the results were obtained using the procedures explained above so that one of ordinary skill in the art can readily replicated the results.



Human Diseases Cured By and Pathogens Killed by the Inventive Silver Composition:



TABLE-US-00021 Disease Pathogen Effective Concentration Boils Staphylococcus aureus Killed @ 5 ppm Osteomyelitis Staphylococcus aureus Killed @ 5 ppm Bacillary Dysentery Shigella boydii Killed @ 2.5 ppm Burn Infections Pseudomonas aeruginosa Killed @ 5 ppm Dental Plaque Streptococcus mutans Killed @ 5 ppm Diarrhea (Bloody) Shigella boydii Killed @ 2.5 ppm Diarrhea Escherichia coli Killed @ 2.5 ppm Ear Infection Haemophilus influenzae Killed @ 1.25 ppm Ear Infection Streptococcus pneumonie Killed @ 2.5 ppm Enteric Fever Salmonella tyhimurium Killed @ 2.5 ppm Epiglottitis (In children) Haemophilus influenzae Killed @ 1.25 ppm Eye Infections Staphylococcus aureus Killed @ 5 ppm Corneal Ulcers-Keratitis Pseudomonas aeruginosa Killed @ 5 ppm Food Poisoning Salmonella arizona Killed @ 5 ppm Food Poisoning Salmonella tyhimurium Killed @ 2.5 ppm Food Poisoning Escherichia coli Killed @ 2.5 ppm Endocarditis Streptococcus faecalis Killed @ 2.5 ppm Endocarditis Streptococcus gordonii Killed @ 5 ppm Meningitis Haemophilus influenzae Killed @ 1.25 ppm Meningitis Enterobacter aerogenes Killed @ 2.5 ppm Meningitis Pseudomonas aeruginosa Killed @ 5 ppm Meningitis Streptococcus pneumonie Killed @ 2.5 ppm Nosocomial Infections Klebsiella pneumoniae Killed @ 2.5 ppm Nosocomial Infections Pseudomonas aeruginosa Killed @ 5 ppm Nosocomial Infections (From Streptococcus pyogenes Killed @ 1.25 ppm hospitals) Pneumonia Staphylococcus aureus Killed @ 5 ppm Pneumonia Haemophilus influenzae Killed @ 1.25 ppm Pneumonia Pseudomonas aeruginosa Killed @ 5 ppm Pneumonia Streptococcus pneumonie Killed @ 2.5 ppm Respiratory Tract Infections Streptococcus pyogenes Killed @ 1.25 ppm Respiratory Tract Infections E. coli Killed @ 2.5 ppm,, Respiratory Tract Infections Klebsiella pneumoniae Killed @ 2.5 ppm Scarlet Fever Streptococcus pyogenes Killed @ 1.25 ppm Septicemia Enterobacter aerpyogenes Killed @ 2.5 ppm Sinus Infections Haemophilus influenzae Killed @ 1.25 ppm Sinusitis Streptococcus pneumonie Killed @ 2.5 ppm Impetigo Staphylococcus aureus Killed @ 1.25 ppm Skin Infections Staphylococcus aureus Killed @ 5 ppm Skin Infections Streptococcus pyogenes Killed @ 1.25 ppm Strep Throat Streptococcus pyogenes Killed @ 1.25 ppm Suppurative Arthritis Haemophilus influenzae Killed @ 1.25 ppm Throat Infections Haemophilus influenzae Killed @ 1.25 ppm Tooth Decay Streptococcus mutans Killed @ 5 ppm Urethritis (Men) Trichomonas vaginalis Killed @ 10 ppm Urinary Tract Infections E. coli Killed @ 2.5 ppm Urinary Tract Infections Klebsiella pneumoniae Killed @ 2.5 ppm Urinary Tract Infections Pseudomonas aeruginosa Killed @ 5 ppm Urinary Tract Infections Streptococcus faecalis Killed @ 2.5 ppm Urinary Tract Infections Enterobacter aerpyogenes Killed @ 2.5 ppm Vaginitis (Women) Trichomonas vaginalis Killed @ 10 ppm Wound Infections Escherichia coli Killed @ 2.5 ppm Wound Infections Enterobacter aerpyogenes Killed @ 2.5 ppm Wound Infections Klebsiella pneumoniae Killed @ 2.5 ppm Wound Infections Pseudomonas aeruginosa Killed @ 5 ppm Wound Infections Streptococcus faecalis Killed @ 2.5 ppm Yeast Infections Candida albicans Killed @ 10 ppm



The following claims are thus to be understood to include what is specifically illustrated and described above, what is conceptually equivalent, what can be obviously substituted and also what essentially incorporates the essential idea of the invention. Those skilled in the art will appreciate that various adaptations and modifications of the just-described preferred embodiment can be configured without departing from the scope of the invention. The illustrated embodiment has been set forth only for the purposes of example and that should not be taken as limiting the invention. Therefore, it is to be understood that, within the scope of the appended claims, the invention may be practiced other than as specifically described herein.

Dawn